Chief Technology Officer, Chris Brough, Ph.D., will lead a discussion on what it takes to successfully scale amorphous solid dispersions from early development into manufacturing. He will explore common scale-up challenges across ASD technologies, the data and decisions that matter most as programs move toward GMP, and how early formulation and process choices can either enable or complicate downstream execution. KinetiSol™ Technology will be highlighted as part of AustinPx’s broader ASD capabilities, with perspective on how its operating principles, particle characteristics, and rapid prototyping approach can simplify scale-up for the right molecules. This 30-minute session includes a 25-minute presentation followed by live Q&A.